CancerSEEK

Aliases:
This biomarker is also known as:
  • CancerSEEK

Description…

Detection of genetic mutations associated with pancreatic and ovarian cancer. FDA approved in 2019. Commercial partner is Thrive Earlier Detection Corp. From https://thrivedetect.com/cancerseek/: CancerSEEK is a blood test (also called a liquid biopsy) designed to detect multiple types of cancer at the earliest stages possible, before noticeable symptoms occur.

Datasets

There are no datasets associated with this biomarker.

Attributes
QA State: Curated
Type: Genetic
HGNC Name:

The following organs have data associated with this biomarker…

Attributes

Phase: 4
QA State: Curated
Organ-specific information for this biomarker is currently being annotated or is "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access to this biomarker.

Attributes

Phase: 4
QA State: Curated
Organ-specific information for this biomarker is currently being annotated or is "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access to this biomarker.

Organ-specific information for this biomarker is currently being annotated or is "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access to this biomarker.

Version 5.1.0